Cm Life Sciences News Today

SomaLogic Inc. (Nasdaq: SLGC) said Thursday evening that its $1 billion merger with California-based Standard BioTools Inc. (Nasdaq: LAB) is expected to be finalized Friday after shareholders for the Boulder biotech company voted this week to consummate the combination. 

Files Preliminary Proxy Statement to Solicit Shareholders to Oppose the Merger Intends to Vote AGAINST the Conflict-Plagued and Excessively Dilutive Transaction, Which Stands to Unduly Benefit...

/PRNewswire/ -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CM Life Sciences III Inc....

NEW YORK, Oct. 26, 2023 /PRNewswire/ -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CM Life Sciences III Inc.  , which was...

Shareholder rights law firm Robbins LLP is investigating EQRx, Inc. to determine whether certain EQRx officers and directors violated securities laws and breached fiduciary duties to...

HYAC | Complete Haymaker Acquisition Corp. 4 stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Following difficult recent months for EQRx, the biotech is being bought by Revolution Medicines in an all-stock transaction that secures $1 billion in additional capital for the oncology company.

GeneDx Holdings Corp. (NASDAQ:WGS – Get Rating) Director Richard C. Pfenniger, Jr. bought 5,000 shares of the company’s stock in a transaction dated Thursday, May 18th. The shares were acquired at an average cost of $5.90 per share, with a total value of $29,500.00. Following the acquisition, the director now directly owns 5,918 shares of […]

GeneDx Holdings Corp. (NASDAQ:WGS – Get Rating) Director Richard C. Pfenniger, Jr. bought 5,000 shares of the company’s stock in a transaction dated Thursday, May 18th. The shares were acquired at an average cost of $5.90 per share, with a total value of $29,500.00. Following the acquisition, the director now directly owns 5,918 shares of […]

GeneDx (NASDAQ:WGS – Get Rating) and P3 Health Partners (NASDAQ:PIII – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, dividends and profitability. Institutional and Insider Ownership 56.0% of GeneDx shares are […]